Michael L. Blum - Jan 9, 2023 Form 4/A - Amendment Insider Report for Homology Medicines, Inc. (FIXX)

Role
Chief Commercial Officer
Signature
/s/ Paul Alloway, Attorney-in-Fact for Michael L. Blum
Stock symbol
FIXX
Transactions as of
Jan 9, 2023
Transactions value $
$0
Form type
4/A - Amendment
Date filed
1/20/2023, 03:05 PM
Date Of Original Report
Jan 11, 2023
Previous filing
Jan 4, 2023
Next filing
Feb 27, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding FIXX Common Stock 9.41K Jan 9, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amended Form 4 is being filed to correct the aggregate common stock holdings of the Reporting Person. On each of January 4, 2023 and January 11, 2023, the Reporting Person filed a Form 4 that inadvertently re-reported Employee Stock Purchase Plan ("ESPP") shares that were previously reported. Accordingly, the common stock holdings in column 5 of Table I have been reduced by 630 ESPP shares.